Blood coagulation parameter abnormalities in hospitalized patients with confirmed COVID-19 in Ethiopia

Coagulopathy and thromboembolic events are among the complications of Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 patients are important prognostic factors of disease severity. The aim of this study was to analyze coagulation profiles of hospitalized COVID-19 pa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one Jg. 16; H. 6; S. e0252939
Hauptverfasser: Araya, Shambel, Mamo, Mintesnot Aragaw, Tsegay, Yakob Gebregziabher, Atlaw, Asegdew, Aytenew, Aschalew, Hordofa, Abebe, Negeso, Abebe Edao, Wordofa, Moges, Niguse, Tirhas, Cheru, Mahlet, Tamir, Zemenu
Format: Journal Article
Sprache:Englisch
Veröffentlicht: San Francisco Public Library of Science 21.06.2021
Public Library of Science (PLoS)
Schlagworte:
Abnormalities
Biology and Life Sciences
Biotechnology
Blood
Blood clotting
Blood coagulation
Coagulation
Computer programs
Corona
Coronaviruses
COVID-19
Data analysis
Drafting software
Editing
Ethics
Funding
Health sciences
Health services
Infections
Medical laboratories
Medical prognosis
Medical research
Medical schools
Medicine and Health Sciences
Methodology
Parameters
Patients
People and Places
Polymerase chain reaction
R&D
Research & development
Research ethics
Respiratory distress syndrome
Risk factors
Severe acute respiratory syndrome
Severe acute respiratory syndrome coronavirus 2
Sociodemographics
Software
Statistical analysis
Supervision
Values
Viral diseases
Viruses
Visualization
Ethiopia
Addis Ababa Ethiopia
ISSN:1932-6203, 1932-6203
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Coagulopathy and thromboembolic events are among the complications of Corona Virus disease 2019 (COVID-19). Abnormal coagulation parameters in COVID-19 patients are important prognostic factors of disease severity. The aim of this study was to analyze coagulation profiles of hospitalized COVID-19 patients in Addis Ababa, Ethiopia. This prospective cross-sectional study was conducted among 455 Covid-19 patients admitted at Millennium COVID-19 care and treatment center, Addis Ababa, Ethiopia from July 1- October 23, 2020. Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT) and International normalized ratio (INR) were determined on HUMACLOT DUE PLUS® coagulation analyzer (Wiesbaden, Germany). In all statistical analysis of results, p<0.05 was defined as statistically significant. A prolonged prothrombin time was found in 46.8% of study participants with COVID-19 and a prolonged prothrombin time and elevated INR in 53.3% of study subjects with severe and 51% of critically COVID patients. Thrombocytopenia was detected in 22.1% of COVID-19 patients. 50.5% and 51.3% of COVID-19 patients older than 55 years had thrombocytopenia and prolonged APTT respectively. In this study, prolonged prothrombin time and elevated INR were detected in more than 50% of severe and critical COVID-19 patients. Thrombocytopenia and prolonged APTT were dominant in COVID-19 patients older than 55 years. Thus, we recommend emphasis to be given for monitoring of platelet count, PT, APTT and INR in hospitalized and admitted COVID-19 patients.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Undefined-3
Competing Interests: The authors have declared that no competing interests exist.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0252939